| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q4 2013 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 36 | Q3 2023 | 5.9% |
| GILEAD SCIENCES INC | 36 | Q3 2023 | 3.1% |
| MERCK & CO INC NEW | 36 | Q3 2023 | 2.6% |
| REGENERON PHARMACEUTICALS | 36 | Q3 2023 | 2.0% |
| JOHNSON & JOHNSON | 36 | Q3 2023 | 2.5% |
| BIOGEN INC | 36 | Q3 2023 | 2.6% |
| PROCTER & GAMBLE CO | 36 | Q3 2023 | 1.9% |
| VERTEX PHARMACEUTICALS INC | 36 | Q3 2023 | 2.1% |
| META PLATFORMS INC | 36 | Q3 2023 | 1.6% |
| VISA INC | 36 | Q3 2023 | 1.2% |
View Candriam S.C.A.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-06 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-10 |
View Candriam S.C.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.